194 related articles for article (PubMed ID: 23717701)
21. Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host.
Wang J; Marreros N; Rufener R; Hemphill A; Gottstein B; Lundström-Stadelmann B
Exp Parasitol; 2020 Dec; 219():108013. PubMed ID: 33010287
[TBL] [Abstract][Full Text] [Related]
22. To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis.
Gorgas D; Marreros N; Rufener R; Hemphill A; Lundström-Stadelmann B
Parasitology; 2017 Jun; 144(7):937-944. PubMed ID: 28270242
[TBL] [Abstract][Full Text] [Related]
23. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.
Rufener R; Ritler D; Zielinski J; Dick L; da Silva ET; da Silva Araujo A; Joekel DE; Czock D; Goepfert C; Moraes AM; de Souza MVN; Müller J; Mevissen M; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):331-340. PubMed ID: 29933218
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B; Rufener R; Hemphill A
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():121-129. PubMed ID: 32636148
[TBL] [Abstract][Full Text] [Related]
25. Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis.
Jiang H; Wang X; Guo L; Tan X; Gui X; Liao Z; Li Z; Chen X; Wu X
Parasit Vectors; 2023 Nov; 16(1):407. PubMed ID: 37936208
[TBL] [Abstract][Full Text] [Related]
26. Surveillance and management of Echinococcus multilocularis in a wildlife park.
Umhang G; Lahoreau J; Hormaz V; Boucher JM; Guenon A; Montange D; Grenouillet F; Boue F
Parasitol Int; 2016 Jun; 65(3):245-50. PubMed ID: 26780546
[TBL] [Abstract][Full Text] [Related]
27. Morphological changes of larval Echinococcus multilocularis in mice treated with albendazole or mebendazole.
Nakaya K; Oomori Y; Kutsumi H; Nakao M
J Helminthol; 1998 Dec; 72(4):349-54. PubMed ID: 9858633
[TBL] [Abstract][Full Text] [Related]
28. Alveolar echinococcosis in a Thai patient after migration to an endemic area in Central Europe.
Warnnissorn N; Uiprasertkul M; Atisook K; Sirivatanauksorn Y; Limawongpranee S
Travel Med Infect Dis; 2006 Jan; 4(1):34-7. PubMed ID: 16887723
[No Abstract] [Full Text] [Related]
29. The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
Lundström-Stadelmann B; Rufener R; Ritler D; Zurbriggen R; Hemphill A
Food Waterborne Parasitol; 2019 Jun; 15():e00040. PubMed ID: 32095613
[TBL] [Abstract][Full Text] [Related]
30. A Rapid and Convenient Method for in Vivo Fluorescent Imaging of Protoscolices of Echinococcus multilocularis.
Yang T; Wang S; Zhang X; Xia J; Guo J; Hou J; Zhang H; Chen X; Wu X
Korean J Parasitol; 2016 Apr; 54(2):225-31. PubMed ID: 27180584
[TBL] [Abstract][Full Text] [Related]
31. Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode.
Rodrigues JM; Bories C; Emery I; Fessi H; Devissaguet JP; Liance M
Int J Parasitol; 1995 Dec; 25(12):1437-41. PubMed ID: 8719955
[TBL] [Abstract][Full Text] [Related]
32. The combination of carvacrol and albendazole enhanced the efficacy of monotherapy in experimental alveolar echinococcosis.
Lopez LM; Pensel PE; Fabbri J; Albani CM; Elissondo N; Gambino G; Elissondo MC
Acta Trop; 2022 Jan; 225():106198. PubMed ID: 34688631
[TBL] [Abstract][Full Text] [Related]
33. Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Rufener R; Dick L; D'Ascoli L; Ritler D; Hizem A; Wells TNC; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):440-450. PubMed ID: 30396011
[TBL] [Abstract][Full Text] [Related]
34. Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone.
Stettler M; Siles-Lucas M; Sarciron E; Lawton P; Gottstein B; Hemphill A
Antimicrob Agents Chemother; 2001 Aug; 45(8):2256-62. PubMed ID: 11451682
[TBL] [Abstract][Full Text] [Related]
35. In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes.
Jura H; Bader A; Frosch M
Antimicrob Agents Chemother; 1998 May; 42(5):1052-6. PubMed ID: 9593125
[TBL] [Abstract][Full Text] [Related]
36. Recurrent hepatic alveolar echinococcosis: report of the first case in Korea with unproven infection route.
Kim SJ; Kim JH; Han SY; Kim YH; Cho JH; Chai JY; Jeong JS
Korean J Parasitol; 2011 Dec; 49(4):413-8. PubMed ID: 22355210
[TBL] [Abstract][Full Text] [Related]
37. In vitro culture of Echinococcus multilocularis producing protoscoleces and mouse infection with the cultured vesicles.
Wang H; Li J; Guo B; Zhao L; Zhang Z; McManus DP; Wen H; Zhang W
Parasit Vectors; 2016 Jul; 9(1):411. PubMed ID: 27457380
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine.
Wen H; New RR; Muhmut M; Wang JH; Wang YH; Zhang JH; Shao YM; Craig PS
Parasitology; 1996 Aug; 113 ( Pt 2)():111-21. PubMed ID: 8760312
[TBL] [Abstract][Full Text] [Related]
39. Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.
Ingold K; Bigler P; Thormann W; Cavaliero T; Gottstein B; Hemphill A
Antimicrob Agents Chemother; 1999 May; 43(5):1052-61. PubMed ID: 10223913
[TBL] [Abstract][Full Text] [Related]
40. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
